{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:25:35Z","timestamp":1791804335512,"version":"4.3.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Joint Construction Project of Henan Provincial Medical Science and Technology Research Program","award":["LHGJ20230524"],"award-info":[{"award-number":["LHGJ20230524"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-026-07360-x","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T08:54:11Z","timestamp":1784883251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association and exploratory clinical significance of peripheral blood mononuclear cell microRNA-155 with T-Cell subset imbalance in newly diagnosed paediatric immune thrombocytopenia"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhiyin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junke","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youjing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"23","key":"7360_CR1","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","volume":"3","author":"C Neunert","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829\u201366. https:\/\/doi.org\/10.1182\/bloodadvances.2019000966.","journal-title":"Blood Adv"},{"issue":"22","key":"7360_CR2","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","volume":"3","author":"D Provan","year":"2019","unstructured":"Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3(22):3780\u2013817. https:\/\/doi.org\/10.1182\/bloodadvances.2019000812.","journal-title":"Blood Adv"},{"key":"7360_CR3","doi-asserted-by":"publisher","unstructured":"Hillier K, Zobeck M, MacMath D, Chumsky J, Kirk SE, O\u2019Farrell C, et al. Predicting Development of Pediatric Chronic Immune Thrombocytopenia at Disease Onset Using a Statistical Risk Model. Blood. 2026;147(16):1863\u201372. https:\/\/doi.org\/10.1182\/blood.2025028563.","DOI":"10.1182\/blood.2025028563"},{"key":"7360_CR4","doi-asserted-by":"publisher","unstructured":"National Health Commission of the P.R, China. Clinical Diagnosis and Treatment Specification for Pediatric Primary Immune Thrombocytopenia (2019 Edition). Clin Educ Gen Pract. 2019;17(12):1059\u20131062. (in Chinese). https:\/\/doi.org\/10.13558\/j.cnki.issn1672-3686.2019.012.002.","DOI":"10.13558\/j.cnki.issn1672-3686.2019.012.002"},{"key":"7360_CR5","doi-asserted-by":"publisher","first-page":"101222","DOI":"10.1016\/j.blre.2024.101222","volume":"67","author":"JW Semple","year":"2024","unstructured":"Semple JW, Schifferli A, Cooper N, Saad H, Mytych DT, Chea LS, Newland A. Immune thrombocytopenia: Pathophysiology and impacts of Romiplostim treatment. Blood Rev. 2024;67:101222. https:\/\/doi.org\/10.1016\/j.blre.2024.101222.","journal-title":"Blood Rev"},{"issue":"4","key":"7360_CR6","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.3390\/ijms25042163","volume":"25","author":"A Mititelu","year":"2024","unstructured":"Mititelu A, Onis\u00e2i MC, Ro\u0219ca A, Vl\u0103d\u0103reanu AM. Current Understanding of Immune Thrombocytopenia: A Review of Pathogenesis and Treatment Options. Int J Mol Sci. 2024;25(4):2163. https:\/\/doi.org\/10.3390\/ijms25042163.","journal-title":"Int J Mol Sci"},{"issue":"20","key":"7360_CR7","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1182\/blood.2022018380","volume":"141","author":"A Malik","year":"2023","unstructured":"Malik A, Sayed AA, Han P, Tan MMH, Watt E, Constantinescu-Bercu A, et al. The role of CD8\u2009+\u2009T-cell clones in immune thrombocytopenia. Blood. 2023;141(20):2417\u201329. https:\/\/doi.org\/10.1182\/blood.2022018380.","journal-title":"Blood"},{"issue":"1","key":"7360_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/ejh.13705","volume":"108","author":"JR Vrbensky","year":"2022","unstructured":"Vrbensky JR, Nazy I, Clare R, Larch\u00e9 M, Arnold DM. T cell-mediated autoimmunity in immune thrombocytopenia. Eur J Haematol. 2022;108(1):18\u201327. https:\/\/doi.org\/10.1111\/ejh.13705.","journal-title":"Eur J Haematol"},{"key":"7360_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.imlet.2020.05.003","volume":"224","author":"L Chen","year":"2020","unstructured":"Chen L, Gao D, Shao Z, Zheng Q, Yu Q. miR-155 indicates the fate of CD4+\u2009T cells. Immunol Lett. 2020;224:40\u20139. https:\/\/doi.org\/10.1016\/j.imlet.2020.05.003.","journal-title":"Immunol Lett"},{"key":"7360_CR10","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1017\/erm.2021.11","volume":"23","author":"SA Ibrahim","year":"2021","unstructured":"Ibrahim SA, Afify AY, Fawzy IO, El-Ekiaby N, Abdelaziz AI. The curious case of miR-155 in SLE. Expert Rev Mol Med. 2021;23:e11. https:\/\/doi.org\/10.1017\/erm.2021.11.","journal-title":"Expert Rev Mol Med"},{"issue":"27","key":"7360_CR11","doi-asserted-by":"publisher","first-page":"11193","DOI":"10.1073\/pnas.1019536108","volume":"108","author":"M Kurowska-Stolarska","year":"2011","unstructured":"Kurowska-Stolarska M, Alivernini S, Ballantine LE, Asquith DL, Millar NL, Gilchrist DS, et al. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci U S A. 2011;108(27):11193\u20138. https:\/\/doi.org\/10.1073\/pnas.1019536108.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"7360_CR12","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3760\/cma.j.issn.0376-2491.2016.14.008","volume":"96","author":"Y Guo","year":"2016","unstructured":"Guo Y, Qu W, Wang YH, Liu H, Li LJ, Wang HQ, et al. The role of miR-155 in the pathogenesis of immune thrombocytopenia. Natl Med J China. 2016;96(14):1103\u20137. https:\/\/doi.org\/10.3760\/cma.j.issn.0376-2491.2016.14.008.","journal-title":"Natl Med J China"},{"key":"7360_CR13","doi-asserted-by":"publisher","first-page":"118057","DOI":"10.1016\/j.lfs.2020.118057","volume":"257","author":"Y Chang","year":"2020","unstructured":"Chang Y, Chen X, Tian Y, Gao X, Liu Z, Dong X, Wang L, He F, Zhou J. Downregulation of microRNA-155-5p prevents immune thrombocytopenia by promoting macrophage M2 polarization via the SOCS1-dependent PD1\/PDL1 pathway. Life Sci. 2020;257:118057. https:\/\/doi.org\/10.1016\/j.lfs.2020.118057.","journal-title":"Life Sci"},{"issue":"4","key":"7360_CR14","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402\u20138. https:\/\/doi.org\/10.1006\/meth.2001.1262.","journal-title":"Methods"},{"issue":"9","key":"7360_CR15","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1002\/eji.202048794","volume":"51","author":"W Zhang","year":"2021","unstructured":"Zhang W, Liu X, Zhu Y, Liu X, Gu Y, Dai X, Li B. Transcriptional and posttranslational regulation of Th17\/Treg balance in health and disease. Eur J Immunol. 2021;51(9):2137\u201350. https:\/\/doi.org\/10.1002\/eji.202048794.","journal-title":"Eur J Immunol"},{"key":"7360_CR16","doi-asserted-by":"publisher","first-page":"1645932","DOI":"10.3389\/fimmu.2025.1645932","volume":"16","author":"H Chen","year":"2025","unstructured":"Chen H, Xie X, Ma J, Fu L, Wu R, Chen Z. Association of TCR\u03b1\u03b2+\u2009double-negative T cells with the response to glucocorticoids in pediatric patients with immune thrombocytopenia. Front Immunol. 2025;16:1645932. https:\/\/doi.org\/10.3389\/fimmu.2025.1645932.","journal-title":"Front Immunol"},{"key":"7360_CR17","doi-asserted-by":"publisher","first-page":"1499014","DOI":"10.3389\/fimmu.2025.1499014","volume":"16","author":"S Bu","year":"2025","unstructured":"Bu S, Liu M, Yang L, Lee P, Miller H, Park CS, Byazrova M, Filatov A, Benlagha K, Gaber T, Buttgereit F, Gong Q, Zhai Z, Liu C. The function of T cells in immune thrombocytopenia. Front Immunol. 2025;16:1499014. https:\/\/doi.org\/10.3389\/fimmu.2025.1499014.","journal-title":"Front Immunol"},{"issue":"5","key":"7360_CR18","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1073\/pnas.0610731104","volume":"104","author":"RM O\u2019Connell","year":"2007","unstructured":"O\u2019Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A. 2007;104(5):1604\u20139. https:\/\/doi.org\/10.1073\/pnas.0610731104.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"7360_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/ddr.21619","volume":"81","author":"SS Mortazavi-Jahromi","year":"2020","unstructured":"Mortazavi-Jahromi SS, Aslani M, Omidian S, Ahmadzadeh A, Rezaieyazdi Z, Mirshafiey A. Immunopharmacological effect of \u03b2-d-mannuronic acid (M2000), as a new immunosuppressive drug, on gene expression of miR-155 and its target molecules (SOCS1, SHIP1) in a clinical trial on rheumatoid arthritis patients. Drug Dev Res. 2020;81(3):295\u2013304. https:\/\/doi.org\/10.1002\/ddr.21619.","journal-title":"Drug Dev Res"},{"issue":"12","key":"7360_CR20","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00011-022-01643-6","volume":"71","author":"WD Xu","year":"2022","unstructured":"Xu WD, Feng SY, Huang AF. Role of miR-155 in inflammatory autoimmune diseases: a comprehensive review. Inflamm Res. 2022;71(12):1501\u201317. https:\/\/doi.org\/10.1007\/s00011-022-01643-6.","journal-title":"Inflamm Res"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-07360-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-07360-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-07360-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:29:40Z","timestamp":1788233380000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-07360-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7360"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-07360-x","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"24 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Medical Research Ethics Committee of the First Affiliated Hospital of Henan Medical University (Approval Number: EC-LW026-051). Written informed consent was obtained from all parents\/local guardians.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"816"}}